TRENTON, N.J. (AP) — Fewer new prescription drugs will get approved in the U.S. this year than the 30 approved in 2011, a new report predicts.
The decline comes just as an unprecedented tidal wave of generic competition for many top-selling drugs slashes the billions of dollars they had been bringing drugmakers.
Fitch Ratings says the Food and Drug Administration approved 14 innovative drugs in the first half of this year. That's down from 18 in the first half of 2011.
Continue Reading for Free
Register and gain access to:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
NOT FOR REPRINT
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
